Infectious Bronchitis

  • Richard A. Gleckman


It has been estimated that approximately 18 million episodes of bronchitis are treated in an ambulatory care setting in the United States each year.1 These inflammatory events produce troublesome symptoms, often result in absenteeism from work, and, on occasion, threaten the life of the patient. With the introduction of new culture and serological techniques, the infectious organisms contributing to actue bronchitis and the exacerbation of chronic bronchitis are being more completely defined. This chapter reviews contemporary concepts pertaining to the pathogenesis, microbiology, clinical features, differential diagnosis, therapy, and prevention of bronchitis in adults.


Chronic Obstructive Pulmonary Disease Influenza Vaccine Chronic Bronchitis Clavulanic Acid Pneumococcal Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Dixon RE: Economic costs of respiratory tract infections in the United States. Am J Med 1985; 78 (suppl 6B): 45 - 51.PubMedCrossRefGoogle Scholar
  2. 2.
    Glick FH, Gregg MB, Berman B, et al: Pontiac fever. Am J Epidemiol 1978; 107: 149 - 160.PubMedGoogle Scholar
  3. 3.
    Grayston JT, Kuo CC, Wang SP, et al: A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315: 161 - 168.PubMedCrossRefGoogle Scholar
  4. 4.
    MacDonald KL, Osterholm MT, Hedberg CW, et al: Toxic shock syndrome: A newly recognized complication of influenza like illness. JAMA 1987; 257: 1052 - 1058.Google Scholar
  5. 5.
    Stott NCH, West RR: Randomised controlled trial of antibiotics in patients with cough and purulent sputum. Br Med J 1976: 2: 556 - 559.PubMedCrossRefGoogle Scholar
  6. 6.
    Kuhn JJ, Hendley JO, Adams KF, et al: Antitussive effect of guaifenesin in young adults with natural colds. Chest 1982; 82: 7 - 13.CrossRefGoogle Scholar
  7. 7.
    Horadam VW, Sharp JG, Similack JD, et al: Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Ann Intern Med 1981; 94: 454 - 458.PubMedCrossRefGoogle Scholar
  8. 8.
    American Thoracic Society: Definitions and classification of chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis 1962; 85: 762 - 768.Google Scholar
  9. 9.
    Willett EC, Green A, Stampfer MJ, et al: Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317: 1303 - 1309.PubMedCrossRefGoogle Scholar
  10. 10.
    Peto R, Speiger FE, Cochrane AL, et al: The relevance in adults of airflow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am Rev Respir Dis 1983; 128: 491 - 500.PubMedGoogle Scholar
  11. 11.
    Camilli AE, Burrows B, Knudson RI, et al: Longitudinal changes in forced expiratory volume in one second in adults. Am Rev Respir Dis 1987; 135: 794 - 799.PubMedGoogle Scholar
  12. 12.
    Britten N, Davies JMC, Colley JRT: Early respiratory experience and subsequent cough and peak expiratory flow rate in 36 year old men and women. Br Bed J 1987; 294: 1317 - 1320.Google Scholar
  13. 13.
    Irwin RS, Erickson AD, Pratter MR, et al: Prediction of tracheobronchial colonization in current cigarette smokers with chronic obstructive bronchitis. J Infect Dis 1982; 145: 234 - 241.PubMedCrossRefGoogle Scholar
  14. 14.
    Irwin RS, Corroa WM, Erickson AD, et al: Characterization by transtrachaeal aspiration of the tracheobronchial microflora during acute exacerbations of chronic obstructive bronchitis. Am Rev Respir Dis 1980; 121 (suppl): 150.Google Scholar
  15. 15.
    Musher DM, Kubitscheck KR, Crennan J, et al: Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann Intern Med 1983; 99: 444 - 450.CrossRefGoogle Scholar
  16. 16.
    Anthonisen NR, Manfreda J, Warren CPW, et al: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196 - 204.PubMedCrossRefGoogle Scholar
  17. 17.
    Mulks MH, Kamfeld SJ, Plant AG: Specific proteolysis of human IgA by Streptococcus pneumoniae and Haemophilus influenzae. J Infect Dis 1980; 141: 450 - 456.CrossRefGoogle Scholar
  18. 18.
    Mulks MH, Plaut AG: IgA protease production as a characteristic distinguishing pathogenic from harmless Neisseriaceae. N Engl J Med 1978; 299: 973 - 976.PubMedCrossRefGoogle Scholar
  19. 19.
    Musher DM, Goree A, Baughn RE, et al: Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae. Infect Immun 1984; 45: 36 - 40.Google Scholar
  20. 20.
    Raheja AK, Weiss EB: The significance of fever in acute exacerbations of chronic obstructive airways disase. Am Rev Respir Dis 1981; 123 (Suppl): 71.Google Scholar
  21. 21.
    Nicotra MB, Rivera M, Awe RJ: Antibiotic therapy of acute exacerbations of chronic bronchitis. Ann Intern Med 1982; 97: 18 - 21.PubMedCrossRefGoogle Scholar
  22. 22.
    Chodosh S: Acute bacterial exacerbations in bronchitis and asthma. Am J Med 1987; 82 (Suppl 4A): 154 - 163.PubMedGoogle Scholar
  23. 23.
    Chodosh S: Bacampicillin in chronic bronchitis: Clinical experience. Bull NY Acad Med 1983; 59: 505 - 514.Google Scholar
  24. 24.
    Pines A: Trimethoprim—sulfamethoxazole in the treatment and prevention of purulent exacerbations of chronic bronchitis. J Infect Dis 1973; 128 (Suppl): 706 - 709.PubMedCrossRefGoogle Scholar
  25. 25.
    Cooper TJ, Ladusans E, Williams PEO, et al: A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections. J Antimibroc Chemother 1985; 16: 373 - 378.CrossRefGoogle Scholar
  26. 26.
    Rubinstein E, Segev S: Drug interactions of ciproflozacin with other nonantibiotic agents. Am J Med 1987; 82 (Suppl 4A): 119 - 123.PubMedGoogle Scholar
  27. 27.
    Albert RK, Martin TR, Lavois SW: Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 1980; 92: 753 - 758.PubMedCrossRefGoogle Scholar
  28. 28.
    Rice KL, Leatherman, JW, Duane PG, et al: Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 107: 305 - 309.PubMedCrossRefGoogle Scholar
  29. 29.
    Leech JA, Gervais A, Rubin FL: Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease. Can Med Assoc J 1987; 136: 361 - 365.Google Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Richard A. Gleckman

There are no affiliations available

Personalised recommendations